Annexin A1 Is Required for Efficient Tumor Initiation and Cancer Stem Cell Maintenance in a Model of Human Breast Cancer
Triple-negative breast cancer (TNBC) has a poor outcome compared to other breast cancer subtypes, and new therapies that target the molecular alterations driving tumor progression are needed. Annexin A1 is an abundant multi-functional Ca<sup>2+</sup> binding and membrane-associated prote...
Main Authors: | Cameron N. Johnstone, Yan Tu, Shenna Langenbach, David Baloyan, Andrew D. Pattison, Peter Lock, Kara L. Britt, Brian D. Lehmann, Traude H. Beilharz, Matthias Ernst, Robin L. Anderson, Alastair G. Stewart |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/5/1154 |
Similar Items
-
Comparison of porcine and human acellular dermal matrix outcomes in wound healing: a deep dive into the evidence
by: Erin Cihat Saricilar, et al.
Published: (2021-07-01) -
Research progress on the mechanism of annexin A family members in breast cancer
by: NAN Lu, GUO Menjie, GAO Yanan, JIA Hongyan
Published: (2024-03-01) -
Clinical Significance of Annexin A2 Expression in Breast Cancer Patients
by: Lee D. Gibbs, et al.
Published: (2020-12-01) -
Proteomics Reveals mRNA Regulation and the Action of Annexins in Thyroid Cancer
by: Margarida Coelho, et al.
Published: (2023-09-01) -
The Association of Annexin A1 and Chemosensitivity to Osimertinib in Lung Cancer Cells
by: Min-Chun Chuang, et al.
Published: (2021-08-01)